Established in October 2005, the non-beta lactam oral solid dosage formulation manufacturing plant of Radiant Pharmaceuticals Limited (RPL) in Tongi, went into production of capsules and powders for suspension in 2008, and tablets in 2009, under license agreement with F. Hoffmann-La Roche Ltd. of Basel, Switzerland.
The RPL manufacturing facilities are solely for non-beta-lactam products. The facilities at the plant include raw and packaging material warehouses, finished goods warehouses and sections for the manufacturing of tablets, capsules and dry-syrups. No other manufacturing of any kind is carried out on the plant premises. All testing of raw & packaging materials and intermediate and finished goods is done at the QC laboratory of the plant. It has a full-fledged utilities & services section including an Effluent Treatment Plant (ETP).
The plant is managed by qualified personnel for production, quality assurance, quality control, product development, and engineering services, who have years of experience in leading multinational & national pharmaceutical industries. They are supported by a team of skilled and experienced technicians.
RPL's policy is to manufacture products in compliance with WHO GMP guidelines and local regulatory requirements to consistently meet high quality standards.